{Reference Type}: Journal Article
{Title}: Functions of methyltransferase-like 3 in breast cancer: pathogenesis, drug resistance, and therapeutic target.
{Author}: Xiao D;Zhang M;Qu Y;Su X;
{Journal}: Breast Cancer Res
{Volume}: 26
{Issue}: 1
{Year}: 2024 Jul 3
{Factor}: 8.408
{DOI}: 10.1186/s13058-024-01869-8
{Abstract}: Breast cancer (BC) is a highly prevalent malignancy worldwide, with complex pathogenesis and treatment challenges. Research reveals that methyltransferase-like 3 (METTL3) is widely involved in the pathogenesis of several tumors through methylation of its target RNAs, and its role and mechanisms in BC are also extensively studied. In this review, we aim to provide a comprehensive interpretation of available studies and elucidate the relationship between METTL3 and BC. This review suggests that high levels of METTL3 are associated with the pathogenesis, poor prognosis, and drug resistance of BC, suggesting METTL3 as a potential diagnostic or prognostic biomarker and therapeutic target. Collectively, this review provides a comprehensive understanding of how METTL3 functions through RNA methylation, which provides a valuable reference for future fundamental studies and clinical applications.